60
Participants
Start Date
January 20, 2017
Primary Completion Date
August 20, 2021
Study Completion Date
December 30, 2022
Romidepsin
5mg/m2 romidepsin will be administered IV on days 10, 17, and 24 after initiating ART
3BNC117
30 mg/kg 3BNC117 will be administered IV on day 7 and 21 after initiating ART
Antiretrovirals
Combination antiretroviral therapy
Dept. of Infectious Diseases, Aarhus University Hospital, Aarhus
Department of Infectious Diseases, Aalborg
Department of Infectious Diseases, Copenhagen
Department of Infectious Diseases, Hvidovre
Department of Infectious Diseases, Odense
Guy's and St Thomas', London
Imperial College Healthcare NHS Trust, London
Rigshospitalet, Denmark
OTHER
Hvidovre University Hospital
OTHER
Odense University Hospital
OTHER
Aalborg University Hospital
OTHER
Herning Hospital
OTHER
Hammersmith Hospitals NHS Trust
OTHER
St Mary's Hospital, London
OTHER
Aarhus University Hospital
OTHER